ICH Consults On Revised Approaches To Assess Risk Of Reproductive Toxicity Of Drugs
Executive Summary
Changes have been proposed to the international guideline on the methodologies that drug companies should use to test medicinal products to assess the risk of reproductive toxicity. The revised guideline takes into account new testing paradigms that allow enhanced human risk assessment and reduced animal use.